0.25mg Semaglutide on a Syringe: The Starting Dose Explained

The misconception: 0.25mg is 'not enough to work'

A question our prescribers hear most weeks is whether it's worth bothering with the 0.25mg starting dose, because it feels too small to make a difference. It's a reasonable assumption, but it's wrong in an important way. The 0.25mg starting dose exists specifically because it isn't a treatment dose. Its job is to give the body time to adapt to semaglutide before the clinically effective doses begin. Starting lower dramatically reduces early nausea and other gastrointestinal side effects that can otherwise cause people to stop treatment before it has a chance to work. The 0.25mg phase is typically four weeks, after which a prescriber steps the dose upwards. Skipping it or rushing it doesn't speed up results; it generally makes the experience harder to tolerate. If you're weighing up the dose schedule in more detail, the semaglutide dose guide covers each step and what to expect from it.

Licensed Wegovy is dispensed as a pre-filled pen, not a syringe. The standard NHS and private prescription route uses these pens exclusively. If you've encountered a syringe-based context (whether that's a compounded preparation, an insulin pen being repurposed, or a clinic drawing up doses manually) that is a very different situation to using Wegovy as licensed, and one that carries its own clinical considerations.

What 0.25mg on a syringe actually refers to

The syringe question usually comes from one of two places. The first is confusion about units: semaglutide is dosed in milligrams, but syringes are often marked in millilitres or insulin units (IU). These are not interchangeable. A syringe marked at 0.25 does not automatically equal 0.25mg of semaglutide, the concentration of the solution determines how many milligrams are in any given volume. Without knowing the concentration, reading the syringe line tells you very little about the actual dose.

The second source of confusion is unlicensed compounded semaglutide, where doses are drawn up manually from a vial using a syringe. The MHRA has warned publicly about the risks of unregulated semaglutide preparations sold online, including products with incorrect concentrations, unlabelled vials and contamination risks. The licensed medicine, Wegovy, is not supplied this way in the UK. If you are using a syringe to draw up semaglutide, it is worth asking whether the preparation you have is licensed and whether it came through a verified supply chain.

For a practical breakdown of how licensed syringe-equivalent volumes relate to each dose step, the semaglutide syringe conversion chart sets this out clearly alongside the context you need to read it safely.

How the dose escalation actually works from 0.25mg upward

The licensed Wegovy schedule runs from 0.25mg through 0.5mg, 1mg and 1.7mg before reaching the 2.4mg maintenance dose, with approximately four weeks at each step. The MHRA also approved a 7.2mg dose in January 2026, available via a dedicated single-dose pen for eligible adults. Dose increases are not automatic or self-directed, they require a prescriber to review your response to the current dose, including any side effects and how well you've tolerated it.

The Wegovy dose overview explains what each step is for and why the schedule is structured the way it is. One common question is whether it's safe to move to the next dose before four weeks if things feel fine; the clinical reasoning behind that four-week minimum is worth reading before making any decision. Your prescriber holds that call, not the calendar. The NHS medicines page for semaglutide also sets out the standard dosing information in accessible language, which is a useful reference alongside what your prescriber tells you.

If you're looking at the cost side of treatment, the Wegovy cost guide sets out what private treatment typically involves and what you should expect a legitimate service to include.

Getting semaglutide safely through a licensed route

Wegovy in the UK is a prescription-only medicine. That means the only legal way to obtain it is through a valid prescription issued following a clinical assessment. Pre-filled pens through a GPhC-registered pharmacy are the standard form, not vials, not syringes, not unlabelled preparations ordered online. If you've been offered semaglutide in a form that requires drawing up a syringe, check whether the supplier is registered on the GPhC pharmacy register before proceeding.

If you're considering starting treatment or have questions about the dose schedule, a consultation with a clinician is the right first step. Our clinical team reviews every case individually, the process, and who we are, is explained on the about us page. For anything else, the FAQs cover the questions we're asked most often.